目次

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.2.3 BASE NUMBER ESTIMATION
2.3 MARKET FORECAST APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 ASSUMPTIONS
2.5.1 MARKET SHARE ASSUMPTIONS
2.5.2 RESEARCH ASSUMPTIONS
2.6 FACTOR ANALYSIS
2.7 RISK ASSESSMENT
2.8 METHODOLOGY-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY
3.1 KEY INSIGHTS & MARKET HIGHLIGHTS
3.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS
3.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
3.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
3.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

4 PREMIUM INSIGHTS
4.1 CAPNOGRAPHY EQUIPMENT MARKET OVERVIEW
4.2 CAPNOGRAPHY EQUIPMENT MARKET, BY REGION, 2025 VS. 2030 (USD MILLION)
4.3 NORTH AMERICA: CAPNOGRAPHY EQUIPMENT MARKET, BY END USER AND COUNTRY, 2024 (USD MILLION)
4.4 GEOGRAPHIC SNAPSHOT OF CAPNOGRAPHY EQUIPMENT MARKET
4.5 CAPNOGRAPHY EQUIPMENT MARKET: DEVELOPING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.1.1 DRIVERS
5.1.1.1 Increasing prevalence of respiratory diseases
5.1.1.2 Clinical benefits of capnography over pulse oximetry
5.1.1.3 Rising number of surgeries and target diseases requiring CO2 monitoring
5.1.1.4 Technological advancements
5.1.2 RESTRAINTS
5.1.2.1 Complex regulatory framework for approval of capnography equipment
5.1.2.2 High equipment and maintenance costs
5.1.3 OPPORTUNITIES
5.1.3.1 Increased availability of clinical research evidence
5.1.3.2 Growth opportunities for healthcare industry in emerging economies
5.1.3.3 AI and data analytics integration
5.1.4 CHALLENGES
5.1.4.1 Lack of skilled technicians and need for specialized training for operating capnometers
5.2 UNMET NEEDS & WHITE SPACES
5.2.1 UNMET NEEDS IN CAPNOGRAPHY EQUIPMENT MARKET
5.2.2 WHITE SPACE OPPORTUNITIES
5.3 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
5.3.1 INTERCONNECTED MARKETS
5.3.2 CROSS-SECTOR OPPORTUNITIES
5.4 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

6 INDUSTRY TRENDS
6.1 PORTER’S FIVE FORCES ANALYSIS
6.1.1 THREAT OF NEW ENTRANTS
6.1.2 BARGAINING POWER OF SUPPLIERS
6.1.3 BARGAINING POWER OF BUYERS
6.1.4 THREAT OF SUBSTITUTES
6.1.5 INTENSITY OF COMPETITIVE RIVALRY
6.2 MACROECONOMIC OUTLOOK
6.2.1 INTRODUCTION
6.2.2 GDP TRENDS AND FORECAST
6.2.3 TRENDS IN GLOBAL RESPIRATORY CARE DEVICES INDUSTRY
6.2.4 TRENDS IN GLOBAL PATIENT MONITORING DEVICES INDUSTRY
6.3 SUPPLY CHAIN ANALYSIS
6.3.1 PROMINENT COMPANIES
6.3.2 SMALL AND MEDIUM-SIZED ENTERPRISES
6.3.3 END USERS
6.4 ECOSYSTEM ANALYSIS
6.5 PRICING ANALYSIS
6.5.1 INDICATIVE SELLING PRICE OF TOP THREE APPLICATIONS, BY KEY PLAYER (2024)
6.5.2 AVERAGE SELLING PRICE TREND OF CAPNOGRAPHY EQUIPMENT, BY TYPE (2022-2024)
6.5.3 AVERAGE SELLING PRICE TREND OF CAPNOGRAPHY EQUIPMENT, BY REGION (2022-2024)
6.6 TRADE ANALYSIS
6.6.1 IMPORT DATA FOR HS CODE 9018
6.6.2 EXPORT DATA FOR HS CODE 9018
6.7 KEY CONFERENCES & EVENTS, 2025-2026
6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
6.9 INVESTMENT & FUNDING SCENARIO
6.10 CASE STUDY ANALYSIS
6.10.1 CASE STUDY 1: INCORPORATING CAPNOGRAPHY MONITORING IN PATIENT-CONTROLLED ANALGESIA (PCA) POST-OPERATIVE CARE
6.10.2 CASE STUDY 2: AVAILABILITY AND USEFULNESS OF PORTABLE CAPNOMETERS IN CHILDREN WITH TRACHEOSTOMY
6.10.3 CASE STUDY 3: RANDOMIZED CONTROLLED TRIAL OF CAPNOGRAPHY IN CORRECTION OF SIMULATED ET DISLODGEMENT
6.11 IMPACT OF 2025 US TARIFFS ON CAPNOGRAPHY EQUIPMENT MARKET
6.11.1 INTRODUCTION
6.11.2 KEY TARIFF RATES
6.11.3 PRICE IMPACT ANALYSIS
6.11.4 IMPACT ON COUNTRY/REGION
6.11.4.1 US
6.11.4.2 Europe
6.11.4.3 Asia Pacific
6.11.5 IMPACT ON END-USER INDUSTRIES

7 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
7.1 KEY EMERGING TECHNOLOGIES
7.1.1 MAINSTREAM CAPNOGRAPHY
7.1.2 SIDE-STREAM CAPNOGRAPHY
7.1.3 WAVEFORM CAPNOGRAPHY
7.1.4 COMPLEMENTARY TECHNOLOGIES
7.1.4.1 Pulse oximetry
7.1.4.2 Ventilators
7.2 TECHNOLOGY/PRODUCT ROADMAP
7.2.1 SHORT TERM (2025-2027) | FOUNDATION & EARLY COMMERCIALIZATION
7.2.2 MID TERM (2027-2030) | EXPANSION & STANDARDIZATION
7.2.3 LONG TERM (2030-2035+) | MASS COMMERCIALIZATION & DISRUPTION
7.3 PATENT ANALYSIS
7.4 FUTURE APPLICATIONS OF CAPNOGRAPHY EQUIPMENT
7.5 IMPACT OF AI/GEN AI ON CAPNOGRAPHY EQUIPMENT MARKET
7.5.1 TOP USE CASES AND MARKET POTENTIAL
7.5.2 BEST PRACTICES IN CAPNOGRAPHY EQUIPMENT PROCESSING
7.5.3 CASE STUDIES OF AI IMPLEMENTATION IN CAPNOGRAPHY EQUIPMENT MARKET
7.5.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
7.5.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN CAPNOGRAPHY EQUIPMENT MARKET

8 REGULATORY LANDSCAPE
8.1 REGIONAL REGULATIONS AND COMPLIANCE
8.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8.1.2 REGULATORY FRAMEWORK
8.1.2.1 North America
8.1.2.1.1 US
8.1.2.2 Europe
8.1.2.3 Asia Pacific
8.1.2.3.1 Japan
8.1.2.3.2 India
8.1.2.3.3 China
8.1.3 INDUSTRY STANDARDS
8.2 CERTIFICATIONS, LABELING, ECO-STANDARDS

9 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
9.1 DECISION-MAKING PROCESS
9.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
9.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
9.2.2 KEY BUYING CRITERIA
9.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
9.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9.5 MARKET PROFITABILITY
9.5.1 REVENUE POTENTIAL
9.5.2 COST DYNAMICS
9.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS

10 CAPNOGRAPHY EQUIPMENT MARKET, BY PRODUCT
10.1 INTRODUCTION
10.2 EQUIPMENT
10.2.1 MULTIPARAMETER CAPNOMETERS
10.2.1.1 Handheld multiparameter capnometers
10.2.1.1.1 Improved patient safety, portability, and inbuilt audible and visual alarms to aid adoption
10.2.1.2 Conventional multiparameter capnometers
10.2.1.2.1 Increasing number of complex surgeries involving anesthesia to support segmental growth
10.2.2 STANDALONE CAPNOMETERS
10.2.2.1 Handheld standalone capnometers
10.2.2.1.1 Increasing number of emergency care visits and complex surgeries to propel market growth
10.2.2.2 Conventional standalone capnometers
10.2.2.2.1 Easy portability and use in critical care settings to boost segmental growth
10.3 SOFTWARE
10.3.1 BETTER CLINICAL DECISION-MAKING AND PATIENT MANAGEMENT TO FUEL MARKET GROWTH
10.4 CAPNOGRAPHY ACCESSORIES & DISPOSABLES
10.4.1 FAVORABLE REIMBURSEMENT SCENARIO TO SUPPORT MARKET GROWTH

11 CAPNOGRAPHY EQUIPMENT MARKET, BY TECHNOLOGY
11.1 INTRODUCTION
11.2 MAINSTREAM CAPNOGRAPHY
11.2.1 HIGH ACCURACY, FAST RESPONSE TIME, AND IMPROVED SUITABILITY FOR NEONATES TO AID MARKET GROWTH
11.3 SIDESTREAM CAPNOGRAPHY
11.3.1 RELIABLE MEASUREMENT OF END-TIDAL CO2 LEVELS TO PROPEL ADOPTION IN CLINICAL SETTINGS
11.4 MICROSTREAM CAPNOGRAPHY
11.4.1 LIMITATIONS IN BLACK-BODY INFRARED TECHNOLOGY TO LIMIT USAGE IN OPERATING ROOMS

12 CAPNOGRAPHY EQUIPMENT MARKET, BY APPLICATION
12.1 INTRODUCTION
12.2 CARDIAC CARE
12.2.1 INCREASING NUMBER OF CARDIOPULMONARY SURGERIES TO DRIVE MARKET GROWTH
12.3 TRAUMA & EMERGENCY CARE
12.3.1 INCREASING NUMBER OF ROAD ACCIDENTS TO SPUR MARKET GROWTH
12.4 RESPIRATORY MONITORING
12.4.1 RISING PREVALENCE OF TARGET RESPIRATORY CONDITIONS TO SUPPORT MARKET GROWTH
12.5 OTHER APPLICATIONS

13 CAPNOGRAPHY EQUIPMENT MARKET, BY END USER
13.1 INTRODUCTION
13.2 HOSPITALS
13.2.1 FOCUS ON REDUCING AIRWAY-RELATED DEATHS IN ICU PATIENTS TO ACCELERATE MARKET GROWTH
13.3 AMBULATORY SURGERY CENTERS & HOME CARE SETTINGS
13.3.1 INCREASING NUMBER OF REIMBURSEMENT-APPROVED MEDICAL PROCEDURES UNDER ASC PAYMENT SYSTEM TO DRIVE MARKET
13.4 OTHER END USERS

14 CAPNOGRAPHY EQUIPMENT MARKET, BY REGION
14.1 INTRODUCTION
14.2 NORTH AMERICA
14.2.1 US
14.2.1.1 US to dominate North American capnography equipment market during forecast period
14.2.2 CANADA
14.2.2.1 Rising prevalence of target respiratory diseases to support market growth
14.3 EUROPE
14.3.1 GERMANY
14.3.1.1 Developed healthcare infrastructure and high government investments to spur market growth
14.3.2 UK
14.3.2.1 Increasing target patient population and rising healthcare expenditure to propel market growth
14.3.3 FRANCE
14.3.3.1 Growing awareness of capnography monitoring procedures and increasing number of trauma cases to augment market growth
14.3.4 ITALY
14.3.4.1 Rise in diabetes cases and high geriatric population to boost market growth
14.3.5 SPAIN
14.3.5.1 Increasing prevalence of lifestyle diseases to drive demand for capnography equipment
14.3.6 REST OF EUROPE
14.4 ASIA PACIFIC
14.4.1 JAPAN
14.4.1.1 Rising geriatric population and growing prevalence of obesity to augment market growth
14.4.2 CHINA
14.4.2.1 High target patient population and improved inpatient service availability to support market growth
14.4.3 INDIA
14.4.3.1 Favorable regulatory policies and high public healthcare expenditure to aid market growth
14.4.4 AUSTRALIA
14.4.4.1 Growing patient population and rising availability of grants to fuel market growth
14.4.5 SOUTH KOREA
14.4.5.1 Increased focus on R&D activities and high penetration of health insurance to propel market growth
14.4.6 REST OF ASIA PACIFIC
14.5 LATIN AMERICA
14.5.1 BRAZIL
14.5.1.1 Improved healthcare sector and increased private-public investments to drive market
14.5.2 MEXICO
14.5.2.1 Favorable trade environment and easy entry of foreign players to fuel market growth
14.5.3 REST OF LATIN AMERICA
14.6 MIDDLE EAST & AFRICA
14.6.1 GCC COUNTRIES
14.6.1.1 Healthcare infrastructural developments and increased focus on patient safety to drive market
14.6.2 REST OF MIDDLE EAST & AFRICA

15 COMPETITIVE LANDSCAPE
15.1 INTRODUCTION
15.2 KEY PLAYER STRATEGY/RIGHT TO WIN
15.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CAPNOGRAPHY EQUIPMENT MARKET
15.3 REVENUE ANALYSIS, 2020-2024
15.4 MARKET SHARE ANALYSIS, 2024
15.4.1 RANKING OF KEY MARKET PLAYERS
15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
15.5.1 STARS
15.5.2 EMERGING LEADERS
15.5.3 PERVASIVE PLAYERS
15.5.4 PARTICIPANTS
15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
15.5.5.1 Company footprint
15.5.5.2 Region footprint
15.5.5.3 Product footprint
15.5.5.4 Technology footprint
15.5.5.5 Application footprint
15.5.5.6 End-user footprint
15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
15.6.1 PROGRESSIVE COMPANIES
15.6.2 RESPONSIVE COMPANIES
15.6.3 DYNAMIC COMPANIES
15.6.4 STARTING BLOCKS
15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
15.6.5.1 Detailed list of key startups/SMEs
15.6.5.2 Competitive benchmarking of key startups/SMEs
15.7 COMPANY VALUATION & FINANCIAL METRICS
15.7.1 FINANCIAL METRICS
15.7.2 COMPANY VALUATION
15.8 BRAND/PRODUCT COMPARISON
15.9 COMPETITIVE SCENARIO
15.9.1 PRODUCT APPROVALS
15.9.2 DEALS

16 COMPANY PROFILES
16.1 KEY PLAYERS
16.1.1 MEDTRONIC PLC
16.1.1.1 Business overview
16.1.1.2 Products offered
16.1.1.3 Recent developments
16.1.1.3.1 Product approvals
16.1.1.3.2 Deals
16.1.1.4 MnM view
16.1.1.4.1 Right to win
16.1.1.4.2 Strategic choices
16.1.1.4.3 Weaknesses & competitive threats
16.1.2 KONINKLIJKE PHILIPS N.V.
16.1.2.1 Business overview
16.1.2.2 Products offered
16.1.2.3 Recent developments
16.1.2.3.1 Product approvals
16.1.2.3.2 Deals
16.1.2.4 MnM view
16.1.2.4.1 Right to win
16.1.2.4.2 Strategic choices
16.1.2.4.3 Weaknesses & competitive threats
16.1.3 MASIMO CORPORATION
16.1.3.1 Business overview
16.1.3.2 Products offered
16.1.3.3 Recent developments
16.1.3.3.1 Product approvals
16.1.3.3.2 Deals
16.1.3.4 MnM view
16.1.3.4.1 Right to win
16.1.3.4.2 Strategic choices
16.1.3.4.3 Weaknesses & competitive threats
16.1.4 GE HEALTHCARE
16.1.4.1 Business overview
16.1.4.2 Products offered
16.1.4.3 Recent developments
16.1.4.3.1 Product approvals
16.1.4.3.2 Deals
16.1.4.4 MnM view
16.1.4.4.1 Right to win
16.1.4.4.2 Strategic choices
16.1.4.4.3 Weaknesses & competitive threats
16.1.5 BECTON, DICKINSON AND COMPANY
16.1.5.1 Business overview
16.1.5.2 Products offered
16.1.5.3 MnM view
16.1.5.3.1 Right to win
16.1.5.3.2 Strategic choices
16.1.5.3.3 Weaknesses & competitive threats
16.1.6 DRÄGERWERK AG & CO. KGAA
16.1.6.1 Business overview
16.1.6.2 Products offered
16.1.6.3 Recent developments
16.1.6.3.1 Product approvals
16.1.7 NIHON KOHDEN CORPORATION
16.1.7.1 Business overview
16.1.7.2 Products offered
16.1.7.3 Recent developments
16.1.7.3.1 Deals
16.1.8 ICU MEDICAL, INC.
16.1.8.1 Business overview
16.1.8.2 Products offered
16.1.8.3 Recent developments
16.1.8.3.1 Deals
16.1.9 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
16.1.9.1 Business overview
16.1.9.2 Products offered
16.1.9.3 Recent developments
16.1.9.3.1 Product launches
16.1.9.3.2 Deals
16.1.10 ZOLL MEDICAL CORPORATION
16.1.10.1 Business overview
16.1.10.2 Products offered
16.1.10.3 Recent developments
16.1.10.3.1 Deals
16.1.11 EDAN INSTRUMENTS, INC.
16.1.11.1 Business overview
16.1.11.2 Products offered
16.1.12 HAMILTON MEDICAL
16.1.12.1 Business overview
16.1.12.2 Products offered
16.1.12.3 Recent developments
16.1.12.3.1 Product launches
16.1.13 NONIN
16.1.13.1 Business overview
16.1.13.2 Products offered
16.1.13.3 Recent developments
16.1.13.3.1 Product launches
16.1.13.3.2 Deals
16.1.14 SCHILLER
16.1.14.1 Business overview
16.1.14.2 Products offered
16.1.15 RESMED INC.
16.1.15.1 Business overview
16.1.15.2 Products offered
16.2 OTHER PLAYERS
16.2.1 BIONICS CO., LTD.
16.2.2 BPL MEDICAL TECHNOLOGIES
16.2.3 BURTONS MEDICAL EQUIPMENT, LTD.
16.2.4 CRITICARE TECHNOLOGIES, INC.
16.2.5 DIAMEDICA (UK) LIMITED
16.2.6 INFINIUM MEDICAL
16.2.7 SPACELABS HEALTHCARE
16.2.8 NIDEK MEDICAL INDIA
16.2.9 RECORDERS & MEDICARE SYSTEMS PVT. LTD.
16.2.10 ZOE MEDICAL, INCORPORATED

17 APPENDIX
17.1 DISCUSSION GUIDE
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3 CUSTOMIZATION OPTIONS
17.4 RELATED REPORTS
17.5 AUTHOR DETAILS